Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus

Veterinary Microbiology

Volumn 66, Issue 2, 1999, Pages 101-114

  Bouma, A ^a   De Smit, A J ^a   De Kluijver, E P ^a   Terpstra, C ^a   Moormann, R J M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Classical swine fever virus; Pig viruses; Subunit vaccine; Vaccination

Indexed keywords

GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PESTIVIRUS; SWINE; VACCINATION; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BACULOVIRIDAE; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; INSECTS; SWINE; TRANSFECTION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIREMIA;

CLASSICAL SWINE FEVER VIRUS; INSECTA; SUS SCROFA; UNIDENTIFIED BACULOVIRUS;

EID: 0033058772     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(99)00003-6     Document Type: Article

References (24)

1. Bosch J.C., Kaashoek M.J., Kroese A.H., Van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet. Microbiol. 52:1996;223-234.
2. Dahle J., Liess B. Assessment of safety and protective value of a cell culture modified strain C vaccine of hog cholera/classical swine fever virus. Berl Münch. Tierärztl Wschr. 108:1995;20-25.
3. De Jong M.C.M., Kimman T.G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine. 12:1994;761-766.
4. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J.M. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67:1993;5435-5442.
5. König M., Lengsfeld T., Pauly T., Stark R., Thiel H.-J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J. Virol. 69:1995;6479-6486.
6. Kwang J., Littledike E.T., Donis R.O., Dubovi E.J. Recombinant polypeptide from the gp48 region of the bovine viral diarrhoea virus (BVDV) detects serum antibodies in vaccinated and infected cattle. Vet. Microbiol. 32:1992;281-292.
7. Moormann, R.J.M., Van Rijn, P.A., De Smit, H.J., Wensvoort, G., Terpstra, C., 1996. Recent developments in pig vaccinology, in: Proc. 14th IPVS Congress, Bologna, Italy, 7-10 July, 25-29.
8. Paton D.J., Ibata G., Edwards S., Wensvoort G. An ELISA detecting antibody to conserved pestivirus epitopes. J. Virol. Meth. 31:1991;315-324.
9. Reed L.J., Muench H. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:1938;709-716.
10. Ressang A.A., Den Boer J.L. A comparison between the cell culture, frozen tissue section and mucosal smear technique for fluorescent antibody in the diagnosis of hog cholera. Tijdsch. Diergen. 93:1968;72-89.
11. Rümenapf T., Stark R., Meyers G., Thiel H.-J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J. Virol. 65:1991;589-597.
12. Terpstra C., Bloemraad M., Gielkens A.L.J. The neutralizing peroxidase-linked assay for detection of antibody against swine fever. Vet. Microbiol. 16:1984;123-128.
13. Terpstra C., Kroese A.H. Potency control of modified live viral vaccines for veterinary use. Vaccine. 14:1996;570-575.
14. Terpstra C., Wensvoort G. The protective value of vaccine-induced neutralizing antibody titres in swine fever. Vet. Microbiol. 16:1988;123-128.
15. Terpstra C., Woortmeyer R., Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch. Tierärztl. Wsch. 97:1990;77-79.
16. Van Oirschot, J.T., 1992. Hog cholera. In: Leman, A.D., Straw, B., Glock, R.D., Mengeling, W.L., Penny, R.H.C., Scholl, E. (Eds.), Diseases of Swine, Iowa State University Press, Ames, USA.
17. Van Oirschot J.T., Gielkens A.L.J., Moormann R.J.M., Berns A.J.M. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet Microbiol. 23:1990;85-101.
18. Van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A.M., Stegeman J.A. The use of marker vaccines in eradication of herpesviruses. J. Biotechnol. 44:1996;75-81.
19. Van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J.M. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J. Gen. Virol. 77:1996;2737-2745.
20. Van Zijl M., Wensvoort G., De Klijver E.P., Hulst M.M., Van der Gulden H., Gielkens A.L.J., Berns A., Moormann R.J.M. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against borth pseudorabies and hog cholera. J. Virol. 65:1991;2761-2765.
21. Wengler, G., Bradley, D.W., Collett, M.S., Heinz, F.X. Schlesinger, R.W., Strauss, J.H., 1995. In: Murphy, F.A, Fauquet, C.M., Bishop, D.H.L., Ghabrial, S.A., Jarvis, A.W., Martelli, G.P., Mayo, M.A., Summers, M.D. (Eds.), Classification and Nomenclature of Viruses, 6th report of the International Committee on the Taxonomy of Viruses, Springer, Berlin, Germany, 415-427.
22. Weiland E., Ahl R., Stark R., Weiland F., Thiel H.-J. A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J. Virol. 66:1992;3677-3682.
23. Weiland E., Stark R., Haas B., Rumenapf T., Meyers G., Thiel H.J. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J. Virol. 64:1990;3563-3569.
24. Wensvoort G., Terpstra C., Boonstra J., Bloemraad M., Van Zaane D. Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis. Vet. Microbiol. 12:1986;101-108.